Kindred Biosciences, Inc.

CIK 1561743 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Kindred Biosciences, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2022SC 13G/A0001193125-22-040403
Feb 14, 2022SC 13G/A0000899140-22-000341
Sep 13, 202140000905718-21-001189
Sep 13, 2021SC 13G/A0000905718-21-001190
Sep 7, 202115-12B0001104659-21-113132
Sep 1, 2021EFFECT9999999995-21-003373
Aug 31, 2021SC 13D/A0000807249-21-000146
Aug 30, 2021SC 13D/A0001104659-21-110760
Aug 30, 202140001250853-21-000091
Aug 30, 202140001250853-21-000092
Aug 30, 20218-K0001561743-21-000072
Aug 30, 202140001250853-21-000086
Aug 30, 202140001250853-21-000088
Aug 30, 202140001250853-21-000090
Aug 30, 202140001250853-21-000087
Aug 30, 202140001250853-21-000085
Aug 30, 2021S-8 POS0001561743-21-000082
Aug 30, 202140001104659-21-110763
Aug 30, 202140001250853-21-000084
Aug 30, 2021POS AM0001561743-21-000074
Aug 30, 202140001250853-21-000089
Aug 30, 2021S-8 POS0001561743-21-000076
Aug 30, 202140001250853-21-000083
Aug 30, 2021S-8 POS0001561743-21-000078
Aug 30, 2021S-8 POS0001561743-21-000084